224 related articles for article (PubMed ID: 35370935)
1. Observation of Clinicopathologic Features of Pituitary Adenoma With Neuronal Differentiation.
Zheng L; Yan X; Hu C; Zhang P; Chen Y; Zheng Q; Hu L; Wang M; Li G; Wu P; Jiang C; Tian J; Zhang S; Wang X
Front Endocrinol (Lausanne); 2022; 13():848762. PubMed ID: 35370935
[TBL] [Abstract][Full Text] [Related]
2. Mixed Gangliocytoma-Pituitary Adenoma: Insights on the Pathogenesis of a Rare Sellar Tumor.
Lopes MB; Sloan E; Polder J
Am J Surg Pathol; 2017 May; 41(5):586-595. PubMed ID: 28079576
[TBL] [Abstract][Full Text] [Related]
3. Mixed gangliocytoma-pituitary adenoma in the sellar region: a large-scale single-center experience.
Yang B; Yang C; Sun Y; Du J; Liu P; Jia G; Jia W; Zhang Y; Wang J; Xu Y; Wang S
Acta Neurochir (Wien); 2018 Oct; 160(10):1989-1999. PubMed ID: 30109498
[TBL] [Abstract][Full Text] [Related]
4. Ganglion cell containing pituitary adenomas: signs of neuronal differentiation in adenoma cells.
Kontogeorgos G; Mourouti G; Kyrodimou E; Liapi-Avgeri G; Parasi E
Acta Neuropathol; 2006 Jul; 112(1):21-8. PubMed ID: 16699777
[TBL] [Abstract][Full Text] [Related]
5. Pituitary adenoma-neuronal choristoma is a pituitary adenoma with ganglionic differentiation.
Nguyen MT; Lavi E
Exp Mol Pathol; 2015 Dec; 99(3):628-31. PubMed ID: 26551086
[TBL] [Abstract][Full Text] [Related]
6. Acromegaly associated with mixed pituitary adenoma-gangliocytoma and Rathke's cleft cyst.
Azarpira N; Pakbaz S; Torabineghad S; Musavi J; Rakei M
Turk Neurosurg; 2013; 23(4):527-30. PubMed ID: 24101276
[TBL] [Abstract][Full Text] [Related]
7. Intrasellar gangliocytomas associated with acromegaly.
Kurosaki M; Saeger W; Lüdecke DK
Brain Tumor Pathol; 2002; 19(2):63-7. PubMed ID: 12622135
[TBL] [Abstract][Full Text] [Related]
8. Transsphenoidal Surgery for Mixed Pituitary Gangliocytoma-Adenomas.
Shepard MJ; Elzoghby MA; Ghanim D; Lopes MBS; Jane JA
World Neurosurg; 2017 Dec; 108():310-316. PubMed ID: 28887280
[TBL] [Abstract][Full Text] [Related]
9. Sellar gangliocytoma with adrenocorticotropic and prolactin adenoma.
Kissiedu JO; Prayson RA
J Clin Neurosci; 2016 Feb; 24():141-2. PubMed ID: 26314658
[TBL] [Abstract][Full Text] [Related]
10. Mixed pituitary adenoma and gangliocytoma associated with acromegaly--case report.
Asada H; Otani M; Furuhata S; Inoue H; Toya S; Ogawa Y
Neurol Med Chir (Tokyo); 1990 Aug; 30(8):628-32. PubMed ID: 1703643
[TBL] [Abstract][Full Text] [Related]
11. Combined sellar gangliocytoma and pituitary adenoma in acromegaly or Cushing's disease. A report of 3 cases.
Saeger W; Puchner MJ; Lüdecke DK
Virchows Arch; 1994; 425(1):93-9. PubMed ID: 7921420
[TBL] [Abstract][Full Text] [Related]
12. 'Gangliocytomas' of the pituitary: a heterogeneous group of lesions with differing histogenesis.
Geddes JF; Jansen GH; Robinson SF; Gömöri E; Holton JL; Monson JP; Besser GM; Révész T
Am J Surg Pathol; 2000 Apr; 24(4):607-13. PubMed ID: 10757410
[TBL] [Abstract][Full Text] [Related]
13. Pituitary Gangliocytoma Producing TSH and TRH: A Review of "Gangliocytomas of the Sellar Region".
Sakata K; Fujimori K; Komaki S; Furuta T; Sugita Y; Ashida K; Nomura M; Morioka M
J Clin Endocrinol Metab; 2020 Oct; 105(10):3109-21. PubMed ID: 32706866
[TBL] [Abstract][Full Text] [Related]
14. Intrasellar pituitary gangliocyto-adenoma presenting with acromegaly: case report.
Morikawa M; Tamaki N; Kokunai T; Imai Y
Neurosurgery; 1997 Mar; 40(3):611-4; discussion 614-5. PubMed ID: 9055303
[TBL] [Abstract][Full Text] [Related]
15. Ganglion cell tumours in the sella turcica in close morphological connection with pituitary adenomas.
Matyja E; Maksymowicz M; Grajkowska W; Zieliński G; Kunicki J; Bonicki W; Witek P; Naganska E
Folia Neuropathol; 2015; 53(3):203-18. PubMed ID: 26443311
[TBL] [Abstract][Full Text] [Related]
16. Neuronal differentiation and expression of neural epitopes in pituitary adenomas.
Johnson MD; Fan X; Bourne P; Walters D
J Histochem Cytochem; 2007 Dec; 55(12):1265-71. PubMed ID: 17875653
[TBL] [Abstract][Full Text] [Related]
17. Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1.
Asa SL; Mete O; Riddle ND; Perry A
Endocr Pathol; 2023 Sep; 34(3):273-278. PubMed ID: 37268858
[TBL] [Abstract][Full Text] [Related]
18. Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNF.
Diaz-Rodriguez E; Garcia-Rendueles AR; Ibáñez-Costa A; Gutierrez-Pascual E; Garcia-Lavandeira M; Leal A; Japon MA; Soto A; Venegas E; Tinahones FJ; Garcia-Arnes JA; Benito P; Angeles Galvez M; Jimenez-Reina L; Bernabeu I; Dieguez C; Luque RM; Castaño JP; Alvarez CV
Endocrinology; 2014 Nov; 155(11):4329-40. PubMed ID: 25137025
[TBL] [Abstract][Full Text] [Related]
19. Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas.
Lee JC; Pekmezci M; Lavezo JL; Vogel H; Katznelson L; Fraenkel M; Harsh G; Dulai M; Perry A; Tihan T
Endocr Pathol; 2017 Dec; 28(4):287-292. PubMed ID: 28994039
[TBL] [Abstract][Full Text] [Related]
20. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
